We are live on
!
Find out more
MP
MFN Partners Portfolio holdings
AUM
$4.77B
1-Year Est. Return
72.29%
This Fund
S&P 500
This Quarter
Est. Return
+7.77%
1 Year Est. Return
+72.29%
3 Year Est. Return
+200.41%
5 Year Est. Return
+244.77%
10 Year Est. Return
–
AUM
$620M
AUM Growth
+$30.6M
(+5.2%)
Cap. Flow
-$6.42M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
90.83%
Holding
20
New
4
Increased
3
Reduced
–
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fox Class A
FOXA
|
+$92.3M |
| 2 |
PG&E
PCG
|
+$47.7M |
| 3 |
FG
FGL Holdings Ordinary Shares
FG
|
+$20.9M |
| 4 |
Takeda Pharmaceutical
TAK
|
+$15.8M |
| 5 |
Navient
NAVI
|
+$7.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$202M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$15.6M |
| 3 |
American International
AIG
|
+$15.4M |
| 4 |
Synchrony
SYF
|
+$7.7M |
| 5 |
SN
Sanchez Energy Corporation
SN
|
+$419K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.28% |
| 2 | Communication Services | 19.63% |
| 3 | Energy | 13.18% |
| 4 | Utilities | 11.48% |
| 5 | Financials | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $95.2M | 15.35% |
650,101
| – | – |
|
|
2
Fox Class A
FOXA
$24.8B
| $87M | 14.03% |
+2,369,331
| New | +$92.3M |
|
|
3
PG&E
PCG
$39B
| $71.2M | 11.48% |
4,000,000
+2,950,000
| +281% | +$47.7M |
|
4
Ironwood Pharmaceuticals
IRWD
$586M
| $66.8M | 10.78% |
5,897,812
| – | – |
|
5
Cheniere Energy
LNG
$54.2B
| $51.3M | 8.27% |
750,000
| – | – |
|
6
CALL
Bristol-Myers Squibb
BMY
$129B
| $47.7M | 7.7% |
+1,000,000
| New | +$49.8M |
|
7
XPO
XPO
$23.4B
| $45.4M | 7.33% |
2,444,674
+41,457
| +2% | +$796K |
|
|
GTT
8
DELISTED
GTT Communications, Inc.
GTT
| $34.7M | 5.6% |
1,000,000
| – | – |
|
9
Goldman Sachs
GS
$289B
| $33.4M | 5.38% |
173,811
| – | – |
|
|
PXD
10
DELISTED
Pioneer Natural Resource Co.
PXD
| $30.5M | 4.91% |
200,000
| – | – |
|
|
FG
11
DELISTED
FGL Holdings Ordinary Shares
FG
| $23.6M | 3.81% |
3,000,000
+2,635,338
| +723% | +$20.9M |
|
|
12
Takeda Pharmaceutical
TAK
$56.7B
| $16M | 2.58% |
+785,000
| New | +$15.8M |
|
13
Aclaris Therapeutics
ACRS
$715M
| $8.98M | 1.45% |
1,500,000
| – | – |
|
|
14
Navient
NAVI
$819M
| $7.52M | 1.21% |
+650,000
| New | +$7.44M |
|
|
RVNC
15
DELISTED
Revance Therapeutics, Inc.
RVNC
| $725K | 0.12% |
46,000
| – | – |
|
|
16
American International
AIG
$42.5B
| – | – |
-390,000
| Closed | -$15.4M |
|
|
17
Synchrony
SYF
$24.4B
| – | – |
-328,022
| Closed | -$7.7M |
|
|
ZAYO
18
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| – | – |
-681,818
| Closed | -$15.6M |
|
|
TFCFA
19
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| – | – |
-4,200,000
| Closed | -$202M |
|
|
SN
20
DELISTED
Sanchez Energy Corporation
SN
| – | – |
-1,550,504
| Closed | -$419K |
|
Similar funds
WAM
MF
CA
RC
GAM
JCM
SAMU
MFN Partners's Q1 2019 Portfolio in Review
As of Q1 2019, MFN Partners held 20 positions worth $620M, up 5.2% from $589M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
MFN Partners's Q1 2019 filing shows 4 new, 3 increased and 5 closed positions. Its largest new stake was Fox Class A: 2,369,331 shares worth $87M. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $202M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.
- MFN Partners's largest Q1 2019 buy was Fox Class A: 2,369,331 shares worth $87M.
- MFN Partners added most to PG&E in Q1 2019, an estimated $47.7M increase.
- MFN Partners fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $202M.
- MFN Partners's ten largest holdings make up 91% of its $620M portfolio in Q1 2019.
- MFN Partners opened 4 new positions and closed 5 in Q1 2019.
- MFN Partners's portfolio value rose 5.2% quarter-over-quarter to $620M.
Based on MFN Partners's 13F filing for Q1 2019, filed 14 May 2019.